Reed SG - Search Results

1

Taking toll: lipid A mimetics as adjuvants and immunomodulators.

Persing DH, Coler RN, Lacy MJ, Johnson DA, Baldridge JR, Hershberg RM, Reed SG. Persing DH, et al. Among authors: reed sg. Trends Microbiol. 2002;10(10 Suppl):S32-7. doi: 10.1016/s0966-842x(02)02426-5. Trends Microbiol. 2002. PMID: 12377566 Review.

2

Development of a leishmaniasis vaccine: the importance of MPL.

Reed SG, Coler RN, Campos-Neto A. Reed SG, et al. Expert Rev Vaccines. 2003 Apr;2(2):239-52. doi: 10.1586/14760584.2.2.239. Expert Rev Vaccines. 2003. PMID: 12899575 Free article. Review.

3

Second-generation vaccines against leishmaniasis.

Coler RN, Reed SG. Coler RN, et al. Among authors: reed sg. Trends Parasitol. 2005 May;21(5):244-9. doi: 10.1016/j.pt.2005.03.006. Trends Parasitol. 2005. PMID: 15837614 Review.

4

New horizons in adjuvants for vaccine development.

Reed SG, Bertholet S, Coler RN, Friede M. Reed SG, et al. Trends Immunol. 2009 Jan;30(1):23-32. doi: 10.1016/j.it.2008.09.006. Epub 2008 Dec 6. Trends Immunol. 2009. PMID: 19059004 Review.

5

Adjuvants for malaria vaccines.

Coler RN, Carter D, Friede M, Reed SG. Coler RN, et al. Among authors: reed sg. Parasite Immunol. 2009 Sep;31(9):520-8. doi: 10.1111/j.1365-3024.2009.01142.x. Parasite Immunol. 2009. PMID: 19691556 Review.

6

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant.

Skeiky YA, Coler RN, Brannon M, Stromberg E, Greeson K, Crane RT, Webb JR, Campos-Neto A, Reed SG. Skeiky YA, et al. Among authors: reed sg. Vaccine. 2002 Sep 10;20(27-28):3292-303. doi: 10.1016/s0264-410x(02)00302-x. Vaccine. 2002. PMID: 12213399

7

Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells.

Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG. Coler RN, et al. Among authors: reed sg. Infect Immun. 2007 Sep;75(9):4648-54. doi: 10.1128/IAI.00394-07. Epub 2007 Jul 2. Infect Immun. 2007. PMID: 17606603 Free PMC article.

8

Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Goto Y, Bogatzki LY, Bertholet S, Coler RN, Reed SG. Goto Y, et al. Among authors: reed sg. Vaccine. 2007 Oct 16;25(42):7450-8. doi: 10.1016/j.vaccine.2007.08.001. Epub 2007 Aug 20. Vaccine. 2007. PMID: 17804125 Free PMC article.

9

Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.

Baldwin SL, Bertholet S, Kahn M, Zharkikh I, Ireton GC, Vedvick TS, Reed SG, Coler RN. Baldwin SL, et al. Among authors: reed sg. Vaccine. 2009 May 18;27(23):3063-71. doi: 10.1016/j.vaccine.2009.03.018. Epub 2009 Mar 26. Vaccine. 2009. PMID: 19428920 Free PMC article.

10

Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.

Baldwin SL, Shaverdian N, Goto Y, Duthie MS, Raman VS, Evers T, Mompoint F, Vedvick TS, Bertholet S, Coler RN, Reed SG. Baldwin SL, et al. Among authors: reed sg. Vaccine. 2009 Oct 9;27(43):5956-63. doi: 10.1016/j.vaccine.2009.07.081. Epub 2009 Aug 11. Vaccine. 2009. PMID: 19679214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters